Management of cerebral vasculopathy in children with sickle cell anaemia.
Powars
D R
DR
Department of Paediatrics, Hematology/Oncology Division, University of Southern California School of Medicine, Los Angeles, CA 90033, USA. powars@hsc.usc.edu
D000293:Adolescent; D000328:Adult; D000465:Algorithms; D000986:Antisickling Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D016206:Databases, Bibliographic; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D018696:Neuroprotective Agents / Q000627:therapeutic use; D012805:Sickle Cell Trait / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D020521:Stroke / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon; D018608:Ultrasonography, Doppler
D000986:Antisickling Agents; D018696:Neuroprotective Agents; D006918:Hydroxyurea